London

Showing 15 posts of 26 posts found.

Touchlight completes expansion of one of world’s largest DNA manufacturing facilities in London

May 24, 2023
Manufacturing and Production DNA, London, Manufacturing Facility, Touchlight, manufacturing

Touchlight, a company that focuses on pioneering enzymatic DNA production, has announced that it has completed the redevelopment and expansion …

merckincweb2

MSD unveils plans for $1.3bn central London research centre

August 19, 2020
Manufacturing and Production, Research and Development London, MSD, pharma

MSD has lifted the lid on plans to build a $1.3 billion research centre in central London.The London Discovery Research …

london-2393098_960_720

London’s water contains high levels of antibiotic-resistant genes, UCL research reveals

July 26, 2019
Medical Communications, Research and Development London, UCL, UK, antibiotic resistance, pharma

Research from University College London has warned that freshwater sources in the English capital of London contain high levels of …

uk

UK to push earlier diagnosis and better treatment with 5 AI-driven technology centres

November 6, 2018
Manufacturing and Production, Research and Development AI, Leeds, London, Oxford, UK, glasgow, pharma

The UK’s Business Secretary has announced the introduction of five specialist collaborative centres across the UK which with leverage advanced …

AI used to forecast cancer progression

September 3, 2018
Sales and Marketing AI, Cancer, ICR, London, ai drug research and development, university of edinburgh

A team of scientists at the Institute of Cancer Research (ICR) in London and the University of Edinburgh have developed …

Realm Therapeutics shares halved after failure of Phase 2 study

August 15, 2018
Research and Development London, Shares, atopic dermatitis, phase 2, stock market

Shares in the London-listed Realm Therapeutics plummeted on Monday after the company reported that a Phase II study of the …

ema_logo

EMA to cut activities as it forecasts loss of 30% of staff

August 2, 2018
Medical Communications, Research and Development EMA, London, UK, amsterdam, brexit, disruption, staff

The European Medicines Agency is set to enact temporary cuts in activities as it prepares for significant disruption in the …

Canary Wharf European Medicines Agency

Landlord demands EMA pay £500m for Canary Wharf lease

July 27, 2018
Medical Communications Canary Wharf, EMA, Litigation, London, amsterdam, court

A British landlord is taking the European Medicines Agency (EMA) to court over a £500 million bill for unpaid rent. …

chris_nowers

Kite Pharma appoints Chris Nowers as Head of Europe

October 14, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chris Nowers, London, kite pharma

Kite Pharma announced on 13 October that it had appointed Chris Nowers as its Head of Europe. Nowers will be …

boris_johnson_in_japan

Mayor of London announces Takeda, UCL R&D partnership

October 14, 2015
Research and Development London, R&D, Takeda, UCL, neurology

Takeda is teaming up with researchers at University College London (UCL) to identify and validate novel target genes for the …

Alzheimer’s Research UK image

£30m drug discovery centres launched to overcome pharma ‘funding fatigue’

February 18, 2015
Research and Development, Sales and Marketing Alzheimer’s Research UK, Cambridge, London, Oxford, dementia, funding, pharma

Three new drug discovery institutes will be launched in the UK with a £30 million commitment to fast-track the development …

Gilead image

Gilead expands UK presence with new London HQ

February 10, 2015
Research and Development, Sales and Marketing Cambridge, Gilead, London, NICE, UK, johnson, medcity, sovaldi, uxbridge

Gilead is to create a new UK commercial secondary headquarters in central London doubling its UK workforce to 600 by …

T cell image

UK makes £30m investment in T-Cell cancer therapy

January 22, 2015
Research and Development, Sales and Marketing Autolus, Cancer, London, T cell, UK, government, oncology, syncona

The UK is making a £30 million R&D investment into a promising new type of cancer treatment and is to …

Latest content